After Hours Summary: Quiet session; ACAD +9.5% jumps on S&P SmallCap 600 inclusion; DAVE -6.8% down on FTC referring its case to DOJ
After Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: None
Companies trading higher in after hours in reaction to news: VSTM +18.8% (FDA Acceptance and Priority Review of New Drug Application for Avutometinib), ACAD +9.5% (replacing Independent Bank Group (IBTX) in the S&P SmallCap 600), CMPO +8.6% (to spin off Resolute Holdings Management), SGML +7.7% (exceeds fourth-quarter production target), AIV +6.1% (to sell properties in Miami for $520 mln), FTAI +3.6% (launches Strategic Capital initiative), GTN +0.7% (to change company name), ADCT +0.3% (completes enrollment of Phase 3 confirmatory clinical trial of ZYNLONTA), PSN +0.1% (selected for $7 billion Austin Light Rail project)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: None
Companies trading lower in after hours in reaction to news: SGMO -56.8% (to regain full rights to Hemophilia A Gene Therapy Program), DAVE -6.8% (FTC refers case to DOJ), RR -5.5% (to delay 10-K filing), CORT -0.3% (submits new drug application to FDA)